Optilume for urethral strictures
Webfor urethral stricture disease in the U.S., but recurrence rates are high, especially after re-treatment. This study investigates the safety and efficacy of the Optilume™ paclitaxel-coated balloon for the treatment of recurrent strictures. Methods: Men with recurrent bulbar strictures ≤2 cm with 1–4 prior WebSep 23, 2024 · The Optilume Drug Coated Balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic hyperplasia (BPH). For more information on Urotronic Inc., and our products, please visit us at urotronic.com
Optilume for urethral strictures
Did you know?
WebThe Optilume® Urethral Drug Coated Balloon is used to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males for urethral strictures of ≤3 cm in length. We are pleased to inform you that the PMA is approved. You may WebDec 13, 2024 · - Optilume® is an effective alternative to traditional endoscopic stricture treatments for male urethral strictures, offering minimally invasive, immediate relief - This …
WebIntroduction: Mechanical balloon dilation and direct visualization internal urethrotomy (DVIU) are the most widely used treatments for urethral stricture disease in the U.S., but recurrence rates are high, especially after re-treatment. This study investigates the safety and efficacy of the Optilume™ paclitaxel-coated balloon for the treatment of recurrent strictures. WebDec 13, 2024 · The Optilume paclitaxel-coated balloon technology was developed in response to patient and physician dissatisfaction with current endoscopic solutions for …
WebApr 12, 2024 · Optilume is the world’s first Drug Coated Balloon approved by the FDA to treat patients with Urethral Strictures. The Optilume Urethral Drug Coated Balloon technology simultaneously dilates and delivers an anti-proliferative medicine to the urethral stricture. WebSep 23, 2024 · The Optilume Drug Coated Balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic...
The Optilume® Urethral Drug Coated Balloon (DCB) uses a drug-coated balloon attached to the end of a urethral catheter to expand the urethra, that may be abnormally narrowed (stricture). The balloon is coated on its outer surface with paclitaxel, a drug that may help preserve the expansion of the … See more A physician inserts the balloon catheter into the portion of the urethra that has a stricture. The balloon is inflated to expand the urethra which will allow improved urine flow. During the balloon expansion, paclitaxel is … See more The Optilume® DCB should not be used in patients who have: 1. A known hypersensitivity to the drug paclitaxel or structurally related compounds. 2. Urologic implants such as penile implants or artificial urinary … See more The Optilume® DCB is used to treat patients, primarily adult males, with urinary symptoms associated with urethral stricture. See more Use of the Optilume® DCB is intended to improve urinary flow rate through at least six months in patients with urethral stricture. See more
WebPurpose: The Optilume® drug-coated balloon (DCB) is a urethral dilation balloon with a paclitaxel coating that combines mechanical dilation for immediate symptomatic relief … partially modifiedWebAnother three great #Optilume cases with an incredible group this evening! Congrats Dr. Alex Tapper, Dr. Auckland, Dr. Smith, and the OR team at Trinity Health… partially mission capableWebJan 5, 2024 · Optilume DCB was granted CE mark approval for use in male anterior urethral strictures in 2024. Optilume's paclitaxel-coated balloon technology was developed in … timothy spridgeon attorneyWebMar 17, 2024 · A total of 127 men were randomised and at 6 months the success rate for Optilume treatment was 75% compared with 27% success for dilatation or urethrotomy. … timothy springer level accessWebMar 1, 2024 · Stricture formation after previous urethral surgery may pose a special challenge. We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the patient remains stricture free with full continence and complete bladder emptying. partially miscible liquids are influenced byWebA Breakthrough Treatment for Urethral Stricture Disease For patients who have failed prior endoscopic management, today there is Optilume® — a breakthrough urethral drug-coated balloon treatment that dilates the urethral lumen and delivers paclitaxel directly to the stricture, significantly reducing the incidence of stricture recurrence.² partially missing limbsWebOptilume Break the stricture cycle Urotronic is focused on developing Drug Coated Balloons which we believe are the future of interventional urology. Learn more about Optilume for Strictures Learn more about Optilume for … partially missing teeth medical term